Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 4
1964 6
1965 3
1966 2
1967 2
1968 6
1969 15
1970 6
1971 9
1972 19
1973 8
1974 17
1975 9
1976 4
1977 16
1978 12
1979 14
1980 6
1981 5
1982 4
1983 3
1984 5
1985 3
1986 3
1987 5
1988 9
1989 8
1990 20
1991 28
1992 33
1993 31
1994 26
1995 31
1996 23
1997 39
1998 46
1999 37
2000 50
2001 48
2002 55
2003 68
2004 51
2005 72
2006 85
2007 100
2008 89
2009 93
2010 119
2011 125
2012 114
2013 144
2014 156
2015 183
2016 170
2017 190
2018 153
2019 168
2020 193
2021 192
2022 190
2023 187
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

3,227 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute. Cheson BD, et al. J Clin Oncol. 2014 Sep 20;32(27):3059-68. doi: 10.1200/JCO.2013.54.8800. J Clin Oncol. 2014. PMID: 25113753 Free PMC article.
The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). A workshop was held at the 11th International Conference on Malignant Lymphoma
The purpose of this work was to modernize recommendations for evaluation, staging, and response assessment of patients with Hodgkin lymph
Genetics of diffuse large B-cell lymphoma.
Pasqualucci L, Dalla-Favera R. Pasqualucci L, et al. Blood. 2018 May 24;131(21):2307-2319. doi: 10.1182/blood-2017-11-764332. Epub 2018 Apr 17. Blood. 2018. PMID: 29666115 Free PMC article. Review.
Diffuse large B-cell lymphoma (DLBCL), the most frequent subtype of lymphoid malignancy, remains a significant clinical challenge, as 30% of patients are not cured. ...This review summarizes current knowledge of the most common genetic alteratio
Diffuse large B-cell lymphoma (DLBCL), the most frequent subtype of lymphoid malignancy, remains a signif
Germinal centres and B cell lymphomagenesis.
Basso K, Dalla-Favera R. Basso K, et al. Nat Rev Immunol. 2015 Mar;15(3):172-84. doi: 10.1038/nri3814. Nat Rev Immunol. 2015. PMID: 25712152 Review.
Germinal centres (GCs) are involved in the selection of B cells secreting high-affinity antibodies and are also the origin of most human B cell lymphomas. Recent progress has been made in identifying the functionally relevant stages of the GC and the complex traffic …
Germinal centres (GCs) are involved in the selection of B cells secreting high-affinity antibodies and are also the origin of most human …
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.
Salles G, Barrett M, Foà R, Maurer J, O'Brien S, Valente N, Wenger M, Maloney DG. Salles G, et al. Adv Ther. 2017 Oct;34(10):2232-2273. doi: 10.1007/s12325-017-0612-x. Epub 2017 Oct 5. Adv Ther. 2017. PMID: 28983798 Free PMC article. Review.
Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined safety profile in patients with various CD20-expressing lymphoid malignancies, including indolent and aggressive forms of B-cell non-Hodgk …
Rituximab is a human/murine, chimeric anti-CD20 monoclonal antibody with established efficacy, and a favorable and well-defined safety profi …
MYD88 L265P Mutation in Lymphoid Malignancies.
Yu X, Li W, Deng Q, Li L, Hsi ED, Young KH, Zhang M, Li Y. Yu X, et al. Cancer Res. 2018 May 15;78(10):2457-2462. doi: 10.1158/0008-5472.CAN-18-0215. Epub 2018 Apr 27. Cancer Res. 2018. PMID: 29703722 Review.
Next-generation sequencing has revealed cancer genomic landscapes, in which over 100 driver genes that, when altered by intragenic mutations, can promote oncogenesis. MYD88 is a driver gene found in hematologic B-cell malignancies. A missense mutation (L265P) changi …
Next-generation sequencing has revealed cancer genomic landscapes, in which over 100 driver genes that, when altered by intragenic mutations …
T follicular helper cells in germinal center B cell selection and lymphomagenesis.
Mintz MA, Cyster JG. Mintz MA, et al. Immunol Rev. 2020 Jul;296(1):48-61. doi: 10.1111/imr.12860. Epub 2020 May 15. Immunol Rev. 2020. PMID: 32412663 Free PMC article. Review.
Germinal centers (GCs) are confined anatomic regions where rapidly proliferating B cells undergo somatic mutation and selection and eventual differentiation into memory B cells or long-lived plasma cells. GCs are also the origin of malignancy, namely follicular lymphoma (F …
Germinal centers (GCs) are confined anatomic regions where rapidly proliferating B cells undergo somatic mutation and selection and eventual …
Antibody and immunotherapy in diffuse large B-cell lymphoma.
Barraclough A, Hawkes EA. Barraclough A, et al. Semin Hematol. 2023 Nov;60(5):338-345. doi: 10.1053/j.seminhematol.2023.11.001. Epub 2023 Nov 23. Semin Hematol. 2023. PMID: 38072722 Review.
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and a heterogeneous B-cell disease. ...Since then, the advent of further "naked" monoclonal antibodies that target malignant B-cells or stimulate the i
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma and a heterogeneous B-
CD5+ diffuse large B-cell lymphoma: a narrative review.
Durani U, Ansell SM. Durani U, et al. Leuk Lymphoma. 2021 Dec;62(13):3078-3086. doi: 10.1080/10428194.2021.1953010. Epub 2021 Jul 21. Leuk Lymphoma. 2021. PMID: 34284686 Review.
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity, and cell surface cluster of differentiation (CD) 5 expression may represent a distinct subset. ...CD5+ DLBCLs are more likely to express Bcl-2, MYC, and MUM1; a large propor
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity, and cell surface cluster of differentiat
Gastrointestinal Tract Lymphomas.
Alvarez-Lesmes J, Chapman JR, Cassidy D, Zhou Y, Garcia-Buitrago M, Montgomery EA, Lossos IS, Sussman D, Poveda J. Alvarez-Lesmes J, et al. Arch Pathol Lab Med. 2021 Dec 1;145(12):1585-1596. doi: 10.5858/arpa.2020-0661-RA. Arch Pathol Lab Med. 2021. PMID: 33836528 Free article. Review.
Primary GI lymphomas are less common, accounting for approximately 10% to 15% of all non-Hodgkin lymphomas. Most non-Hodgkin lymphomas involving the GI tract are of B-cell lineage, of which diffuse large B-cell lymphoma is the most …
Primary GI lymphomas are less common, accounting for approximately 10% to 15% of all non-Hodgkin lymphomas. Most non-Hodgkin lymphomas invol …
Diffuse large B-cell lymphoma: current strategies and future directions.
Cultrera JL, Dalia SM. Cultrera JL, et al. Cancer Control. 2012 Jul;19(3):204-13. doi: 10.1177/107327481201900305. Cancer Control. 2012. PMID: 22710896 Free article. Review.
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common histology of non-Hodgkin lymphoma, representing 25% to 35% of new cases annually. ...METHODS: This article reviews the current protocols applicable to this aggressive …
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common histology of non-Hodgkin lymphoma
3,227 results